Cumberland Pharmaceuticals Reports Annual 2023 Financial Results [Yahoo! Finance]
Cumberland Pharmaceuticals Inc. (CPIX)
Last cumberland pharmaceuticals inc. earnings: 3/18 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.shareholder.com/cpix/index.cfm
Company Research
Source: Yahoo! Finance
March 5, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, announced today that its product portfolio of FDA-approved brands delivered combined revenues of $40 million in 2023 and provided $6 million in cash generated from operations. Cumberland ended the year with $82 million in total assets – including $18 million in cash, $53 million in liabilities and $30 million of shareholders' equity. "In many ways 2023 was a building year for Cumberland , as we continued to integrate our newest products, while also delivering several significant achievements," said Cumberland Pharmaceuticals CEO A.J. Kazimi . "We were pleased to expand the labeling for our Caldolor product to include use in infants, while continuing to build our other brands and progress our clinical programs." Cumberland will report its 2023 financial results and provide a Company update via a conference call today, March 5, 2024 , at 4:30 p.m. Eastern Time HIGHLI
Show less
Read more
Impact Snapshot
Event Time:
CPIX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CPIX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CPIX alerts
High impacting Cumberland Pharmaceuticals Inc. news events
Weekly update
A roundup of the hottest topics
CPIX
News
- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONS [Yahoo! Finance]Yahoo! Finance
- NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONSPR Newswire
CPIX
Sec Filings
- 3/26/24 - Form 4
- 3/26/24 - Form 4
- 3/26/24 - Form 4
- CPIX's page on the SEC website